Hypofractionated versus conventional IMRT in unfavorable intermediate- and high-risk prostate cancer: A phase II comparative study of PSA kinetics, dosimetric and toxicity outcomes.
- DOI
- 10.1016/j.fjurol.2026.103104
- Published
- 2026 Jun
- Container
- The French journal of urology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.fjurol.2026.103104,
title = {Hypofractionated versus conventional IMRT in unfavorable intermediate- and high-risk prostate cancer: A phase II comparative study of PSA kinetics, dosimetric and toxicity outcomes.},
author = {El-Behiri NSSE and Alm El-Din MA and Alkady AM and Moussa RM and Elshebeny MM},
year = {2026},
journal = {The French journal of urology},
doi = {10.1016/j.fjurol.2026.103104},
url = {https://doi.org/10.1016/j.fjurol.2026.103104}
}RIS
TY - JOUR TI - Hypofractionated versus conventional IMRT in unfavorable intermediate- and high-risk prostate cancer: A phase II comparative study of PSA kinetics, dosimetric and toxicity outcomes. AU - El-Behiri NSSE AU - Alm El-Din MA AU - Alkady AM AU - Moussa RM AU - Elshebeny MM PY - 2026 JO - The French journal of urology DO - 10.1016/j.fjurol.2026.103104 UR - https://doi.org/10.1016/j.fjurol.2026.103104 ER -
APA
NSSE, E., MA, A. E., AM, A., RM, M., & MM, E. (2026). Hypofractionated versus conventional IMRT in unfavorable intermediate- and high-risk prostate cancer: A phase II comparative study of PSA kinetics, dosimetric and toxicity outcomes.. The French journal of urology. https://doi.org/10.1016/j.fjurol.2026.103104
Source records
- pubmed · retrieved 2026-09-26T22:44:51.834Z